Pulmonology & Respiratory Care
Request an Appointment Find a Doctor
At Indiana University Health, our physicians help you breathe easier so you can live well. Our physicians have undergone years of training to treat complex pulmonary diseases.
Our multidisciplinary team of healthcare professionals including pulmonologists, critical care physicians, sleep medicine physicians, respiratory therapists and nurses provide comprehensive care. We develop personalized treatment plans including education, lifestyle changes and medicines.
Our expert physicians treat a wide range of conditions from asthma to chronic obstructive pulmonary disease (COPD) to cystic fibrosis, with advanced treatments and clinical trials available through our partnership with the Indiana University School of Medicine.
When you need the most advanced treatment options in the state, you may be referred to the physicians at the Academic Health Center in Indianapolis. At these facilities, we have the technology to provide innovative surgical care, including lung transplants.
Focused on excellence in clinical care and clinical education, Indiana University Health Methodist Hospital comprehensive pulmonary care services include:
- Advanced technology. Includes our telemedicine unit, an electronic intensive care unit (ICU), which allows us to monitor care of patients across the state, 24 hours a day, seven days a week.
- Pulmonary function lab on site. Includes a Pulmonary Rehabilitation Program, which combines exercise with education, breathing retraining and nutritional guidance to help minimize progression of debilitating symptoms in patients with chronic respiratory impairment.
- Interventional Bronchoscopy Program. Includes endobronchial stents and laser therapy for patients with anatomical or cancer-related airway problems.
- Award winning lung transplant team. Features lung-volume reduction surgery to reduce symptoms in patients with severe emphysema.
IU Health Methodist Hospital Pulmonology & Respiratory Care encompasses every level of treatment for patients with breathing disorders and lung diseases. Using advanced diagnostic techniques, including endoscopic bronchial ultrasound, IU Health Methodist Hospital pulmonologists examine the lung to determine the best treatment, therapy and rehabilitation method. Interventions available include rigid bronchoscopy, endobroncial stents and lung transplant.
Jump ahead on this page
The pulmonology and respiratory team at IU Health Methodist Hospital work closely with Indiana University Health Transplant to produce outstanding results for lung transplant patients. Backed by over two decades of experience and notable firsts in the field, the IU Health lung transplant program is nationally ranked and is the only lung transplant program in Indiana.
In addition, IU Health Methodist Hospital is one of the few hospitals in Indiana to qualify under the Centers for Medicare & Medicaid Services to perform Lung Volume Reduction Surgery (LVRS) to help patients with severe emphysema.
Our dedicated surgeons treat a high volume of patients, delivering shorter wait times and enhanced outcomes. As part of a continuum of excellent care, the Pulmonary Rehabilitation Program helps patients grow stronger and return to normal function following surgery.
Our Pulmonary Rehabilitation Program strives to slow down and minimize progression of debilitating symptoms in patients with chronic respiratory impairment by combining exercise with education, breathing retraining and nutritional guidance. Individualized programs incorporate education and therapies to bring relief from a variety of pulmonary diseases such as asthma, COPD, bronchiectasis or fibrosis. In addition, patients with lung cancer, lung transplantation, post-thoracic surgery, ventilator dependency and sleep apnea also use pulmonary rehabilitation services at IU Health in order to grow stronger both physically and emotionally.
Our pulmonology physicians specialize interventional bronchoscopy capabilities, including:
- Endobroncial stents and laser therapy to treat patients with pulmonary fibrosis (scarring of the airway) due to anatomical abnormality or cancer.
- Placement of endobroncial catheters to deliver endobronchial radiation for patients with lung cancer.
- Endoscopic diagnostic techniques to remove lymph nodes or nodules for lung cancer testing and staging.
The Indiana University Health Sleep Disorders Center, accredited by the American Academy of Sleep Medicine, specializes in the evaluation, diagnosis and treatment of sleep disorders. Administered by board-registered physicians and technologists, the IU Health Sleep Disorders Center offers a wide range of sleep studies on an outpatient basis, in a comfortable atmosphere.
If a sleep disorder is diagnosed, treatment may include medicine, surgery or a breathing device such as a continuous positive airway pressure mask (CPAP), mandibular advancement device (MAD), nighttime breathing device to maintain Positive Airway Pressure (PAP), or other oral appliances that open the airway. Support groups and education are also available for patients suffering from a sleep disorder.
The pulmonology specialists at IU Health Methodist Hospital provide breathing tests and diagnostic X-rays to determine the best medical therapy for every individual with asthmatic symptoms. In addition to traditional medical interventions for asthma, advanced therapies, such as thermoplasty, use a probe to deliver energy inside the airways to blunt the asthmatic response to triggers.
At the Indiana University Health Pulmonary Vascular Disease Center, our multidisciplinary team specializes in the definitive and timely diagnosis and treatment of pulmonary hypertension (PH).
Medical treatments for pulmonary arterial hypertension (PAH) currently include continuously infused, inhaled and oral medicines. At the IU Health Pulmonary Vascular Disease Center of Excellence, our physicians have experience with all types of therapeutics and will work to determine which option is best for you.
These can include:
- Blood thinners
- Calcium channel blockers
- Endothelin receptor antagonist (ERA)
- Phosphodiesterase type 5 inhibitors
- Prostacyclin analogues
- Soluble guanylate cyclase inhibitors
- Inhaled nitric oxide
In addition, our physicians have expertise with surgical and interventional treatments for PH, such as:
- Atrial septostomy
- Extracorporeal membrane oxygenation (ECMO)
- Ventricular assist devices (VADs)
- Lung transplantation
Our physicians participate in many research trials and have access to the latest clinical trials for pulmonary function and advanced lung failure. Advances in pulmonary research are facilitated by the seamless collaboration across specialties including pulmonology, cardiology, cardiothoracic surgery and anesthesia. Indiana University Health’s partnership with the Indiana University School of Medicine creates an unparalleled approach to developing future advancements for pulmonary function and advanced lung failure.
Current clinical trials include:
- GRIPHON: A multicenter, double-blind, placebo-controlled, phase 3 study to demonstrate the efficacy and safety of ACT-293987 in patients with pulmonary arterial hypertension (Principal Investigator: William Harvey, MD; Study Coordinator: Deb Broach, RN, BSN, CCRC)
- AMBITION: A randomized, multicenter study of first-line ambrisentan and tadalafil combination therapy in subjects with pulmonary arterial hypertension (Principal Investigator: William Harvey, MD; Study Coordinator: Erin Turk, RN, BSN)
- BEAT: A multicenter, double-blind, randomized, placebo-controlled, phase 3 study to assess the efficacy and safety of oral BPS-314d-MR added-on to treprostinil, inhaled (Tyvaso®) in subjects with pulmonary arterial hypertension (Principal Investigator: William Harvey, MD; Study Coordinator: Erin Turk, RN, BSN)
- ASPIRE: A post-market observational study to assess respiratory tract adverse events in pulmonary arterial hypertension patients treated with treprostinil (Tyvaso®) inhalation solution (Principal Investigator: William Harvey, MD; Study Coordinator: Betty Logan, RN, BSN, CCRC)
- TYTRATE: A patient registry to observe the real-world dosing and titration of tyvaso. (Principal Investigator: Michael Duncan, MD; Study Coordinator: Jean Nash, RN, BSN)
- Clinical investigation of a daily walking program, plus L-arginine supplementation for the treatment of pulmonary arterial hypertension (Principal Investigator: Mary Beth Brown, PhD)
- Pulmonary hypertension in combined pulmonary fibrosis and emphysema (CPFE) syndrome in veterans (Principal Investigator: Timothy Lahm, MD)
- iNOPE: Inhaled nitric oxide to treat pulmonary embolism (Principal Investigator: Jeff Kline, MD)
Basic science research efforts are focused on the investigation of gender and sex hormone effects on PH development (T. Lahm) mechanisms of cell death in right heart failure (T. Lahm), arrested lung development as a risk factor for PH development in adulthood (T. Lahm/S.Ahlfeld), exercise training in PH (M.B. Brown), effects of cigarette smoke on PH development (T. Lahm/I. Petrache), and mechanisms of right heart failure and hemolysis in acute pulmonary embolism (J. Kline).
Services provided at IU Health Pulmonary Vascular Disease Center
- Comprehensive and interdisciplinary diagnostic work-up
- Comprehensive right heart catheterization
- Comprehensive echocardiographic evaluation
- Initiation and monitoring of PAH specific therapies
- Initiation and monitoring of supportive therapies
- Atrial septostomy
- Extracorporeal membrane oxygenation (ECMO)
- Evaluation for lung transplantation
- Pulmonary rehabilitation/exercise training
- Evaluation for chronic thromboembolic pulmonary hypertension surgery
- Evaluation and optimization before elective surgery
- Nutritional support
- Psychosocial support
- Enrollment in clinical trials
- Lung transplantation evaluation
To Schedule an Appointment
We are located at:
1701 N. Senate Blvd.
Indianapolis, IN 46202
Any physician, emergency department, healthcare professional or healthcare agency may refer a patient to IU Health Methodist Hospital emergency care services.
Call direct: 317.916.3525 or 800.265.3220